These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18702650)

  • 1. Body mass index can determine the healing of reflux esophagitis with Los Angeles Grades C and D by esomeprazole.
    Sheu BS; Chang WL; Cheng HC; Kao AW; Lu CC
    Am J Gastroenterol; 2008 Sep; 103(9):2209-14. PubMed ID: 18702650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of body mass index on the application of on-demand therapy for Los Angeles grades A and B reflux esophagitis.
    Sheu BS; Cheng HC; Chang WL; Chen WY; Kao AW
    Am J Gastroenterol; 2007 Nov; 102(11):2387-94. PubMed ID: 17850409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2C19 genotypes determine the efficacy of on-demand therapy of pantoprazole for reflux esophagitis as Los-Angeles grades C and D.
    Sheu BS; Cheng HC; Yeh YC; Chang WL
    J Gastroenterol Hepatol; 2012 Jan; 27(1):104-9. PubMed ID: 21777277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.
    Castell DO; Kahrilas PJ; Richter JE; Vakil NB; Johnson DA; Zuckerman S; Skammer W; Levine JG
    Am J Gastroenterol; 2002 Mar; 97(3):575-83. PubMed ID: 11922549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.
    Devault KR; Johanson JF; Johnson DA; Liu S; Sostek MB
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):852-9. PubMed ID: 16682260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis.
    Kahrilas PJ; Dent J; Lauritsen K; Malfertheiner P; Denison H; Franzén S; Hasselgren G
    Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1385-91. PubMed ID: 17950677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis.
    Sjöstedt S; Befrits R; Sylvan A; Harthon C; Jörgensen L; Carling L; Modin S; Stubberöd A; Toth E; Lind T
    Aliment Pharmacol Ther; 2005 Aug; 22(3):183-91. PubMed ID: 16091055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-dosed pantoprazole accelerates the sustained symptomatic response in overweight and obese patients with reflux esophagitis in Los Angeles grades A and B.
    Chen WY; Chang WL; Tsai YC; Cheng HC; Lu CC; Sheu BS
    Am J Gastroenterol; 2010 May; 105(5):1046-52. PubMed ID: 19904250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):593-8. PubMed ID: 20706150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is body mass index really the most important factor determining the healing of reflux esophagitis by esomeprazole?
    Lo GH
    Am J Gastroenterol; 2009 Mar; 104(3):787; author reply 787-8. PubMed ID: 19240701
    [No Abstract]   [Full Text] [Related]  

  • 11. Symptom resolution does not predict healing of erosive oesophagitis in Chinese.
    Cheung TK; Wong WM; Wong NY; Chan CK; Fung J; Yuen MF; Chan AO; Tong TS; Wong BC
    Digestion; 2007; 75(2-3):128-34. PubMed ID: 17671381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esomeprazole 40 mg administered intravenously has similar safety and efficacy profiles to the oral formulation in patients with erosive esophagitis.
    Schneider H; Van Rensburg C; Schmidt S; Aboo N; Makela H; Nauclér E; Hallerback B; Svedberg LE
    Digestion; 2004; 70(4):250-6. PubMed ID: 15687727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esomeprazole in acute and maintenance treatment of reflux oesophagitis: a multicentre prospective study.
    Atug O; Giral A; Kalayci C; Dolar E; Isitan F; Oguz D; Ovunc O; Ozgur O; Soykan I; Simsek I; Unal S; Yenice N;
    Adv Ther; 2008 Jun; 25(6):552-66. PubMed ID: 18568450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased body mass index after H. pylori eradication for duodenal ulcer predisposes to erosive reflux esophagitis.
    Yang YJ; Sheu BS; Chang WL; Cheng HC; Yang HB
    J Clin Gastroenterol; 2009 Sep; 43(8):705-10. PubMed ID: 19398924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy.
    Kiesslich R; Kanzler S; Vieth M; Moehler M; Neidig J; Thanka Nadar BJ; Schilling D; Burg J; Nafe B; Neurath MF; Galle PR
    Dig Dis; 2004; 22(2):221-7. PubMed ID: 15383765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing?
    Katz PO; Johnson DA; Levine D; Röhss K; Junghard O; Astrand M; Nagy P
    Aliment Pharmacol Ther; 2010 Aug; 32(3):443-7. PubMed ID: 20497146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Feb; 38(2):85-90. PubMed ID: 16289976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole.
    Yang HB; Sheu BS; Wang ST; Cheng HC; Chang WL; Chen WY
    Am J Gastroenterol; 2009 Jul; 104(7):1642-9. PubMed ID: 19436275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers.
    Liu CP; Chen WC; Lai KH; Mar GY; Lin SY; Ger LP; Hsu PI;
    Am J Gastroenterol; 2012 Jul; 107(7):1022-9. PubMed ID: 22508148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials.
    Gralnek IM; Dulai GS; Fennerty MB; Spiegel BM
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1452-8. PubMed ID: 17162239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.